Literature DB >> 26791111

Relation between sex hormones and hepatocellular carcinoma.

T El Mahdy Korah1, E Abd Elfatah Badr2, M Mohamed Emara1, M Ahmed Samy Kohla3, G Gamal Saad Michael1.   

Abstract

Males have higher incidence of hepatocellular carcinoma (HCC) than females. Sex hormones may be a risk factor. The aim was to determine the levels of sex hormones in male and female patients with HCC and cirrhosis versus controls and its possible relationship with HCC. This study was conducted on 90 subjects divided into 40 patients with HCC, 30 patients with liver cirrhosis and 20 apparently healthy subjects complete blood picture, liver function tests. Determination of AFP levels and hormonal assay of oestrogen, progesterone, total testosterone, prolactin, FSH and LH were performed on all subjects. Total testosterone levels were significantly decreased in the two patients groups compared with controls. While oestrogen levels were significantly decreased in the HCC group in comparison with other two groups, prolactin levels were significantly decreased in the HCC group compared with the liver cirrhosis group and increased in the liver cirrhosis group when compared to controls. FSH and LH levels were significantly increased in the HCC group when compared to controls. There is no significant correlation between sex hormones assay and both the size of HCC and degree of cirrhosis in both patient groups. It is concluded that there is no strong relation between sex hormones and HCC when the study was carried out on the levels of sex hormones in patients with HCC.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  Follicle-stimulating hormone; hepatocellular carcinoma; liver cirrhosis; luteinising hormone; oestrogen; progesterone; prolactin; sex hormone; testosterone

Mesh:

Substances:

Year:  2016        PMID: 26791111     DOI: 10.1111/and.12536

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  7 in total

Review 1.  The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones.

Authors:  Linlin Xu; Yuan Yuan; Zhaodi Che; Xiaozhi Tan; Bin Wu; Cunchuan Wang; Chengfang Xu; Jia Xiao
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  GSTM1 and GSTT1 copy number variants and the risk to Thai females of hepatocellular carcinoma.

Authors:  Thanet Sophonnithiprasert; Pensri Saelee; Tanett Pongtheerat
Journal:  J Gastrointest Oncol       Date:  2019-04

3.  Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan.

Authors:  Guan-Woei Tseng; Mei-Chen Lin; Shih-Wei Lai; Cheng-Yuan Peng; Po-Heng Chuang; Wen-Pang Su; Jung-Ta Kao; Hsueh-Chou Lai
Journal:  World J Hepatol       Date:  2021-11-27

4.  Impact of Hypothyroidism on Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.

Authors:  Ahmed Salman; Mohamed Aon; Amr Hussein; Mohamed Salman; Mohamed Tourky; Ahmed Mahmoud; Feras Aljarad; Mohamed Elkaseer; Hossam El-Din Shaaban; Ahmed Moustafa; Ahmed El-Mikkawy; Nahla Gaballa; Heba Abdallah; Zaky Ftouh Zaky Rashed; Hesham Elkassar
Journal:  Int J Gen Med       Date:  2021-09-16

5.  Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States.

Authors:  Pian Liu; Shao-Hua Xie; Shaobo Hu; Xiang Cheng; Tianyi Gao; Chen Zhang; Zifang Song
Journal:  Oncotarget       Date:  2017-07-12

6.  Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.

Authors:  Xiaoli Cheng; Pan Tian; Wengzhong Zheng; Xuetao Yan
Journal:  Cancer Med       Date:  2020-04-13       Impact factor: 4.452

7.  MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis.

Authors:  Yi-Wen Tsai; Kuo-Shyang Jeng; Mu-Kuang He; Yang-Wen Hsieh; Hsin-Hung Lai; Chi-Yu Lai; Chun-Chieh Huang; Chiung-Fang Chang; Chung-Tsui Huang; Guor Mour Her
Journal:  Cells       Date:  2021-12-06       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.